Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT06863805
Eligibility Criteria:
Inclusion Criteria:
* Signed written informed consent,
* Adult (≥18 years) male or female patients
* Histologic diagnosis of advanced thyroid carcinoma confirmed at centralized review,
* well-differentiated thyroid carcinomas, medullary thyroid carcinomas, anaplastic thyroid carcinomas, advanced, candidates for initiation of systemic medical therapy,
* Availability of biomolecular profiling performed by multigenic NGS panel on tumor tissue,
* Measurable disease by conventional imaging adopted in clinical practice (total body CT with mdc, CT-PET with FDG or F-DOPA).
Exclusion Criteria:
* Patients already receiving previous lines of systemic therapy,
* Patients not eligible for systemic therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06863805
Study Brief:
Protocol Section:
NCT06863805